nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Chemosensitisation of PDAC cell lines by the VCP inhibitor NMS-873
|
Astuti, Yuliana |
|
2016 |
16 |
3S |
p. S7- 1 p. |
artikel |
2 |
Circulating biomarkers in pancreatic cancer
|
Brady, Ged |
|
2016 |
16 |
3S |
p. S2- 1 p. |
artikel |
3 |
Developing drug combinations to co-target pancreatic cancer and its supporting stroma
|
Carapuça, Elisabete F. |
|
2016 |
16 |
3S |
p. S4- 1 p. |
artikel |
4 |
In vitro models of drug screening for pancreatic cancer
|
Lam, Hoyin |
|
2016 |
16 |
3S |
p. S8- 1 p. |
artikel |
5 |
Killing cancers by targeting their engines, not their drivers
|
Evan, Gerard |
|
2016 |
16 |
3S |
p. S6-S7 2 p. |
artikel |
6 |
Modifying oncolytic viral therapy for pancreatic cancer
|
Man, Y.K. Stella |
|
2016 |
16 |
3S |
p. S4- 1 p. |
artikel |
7 |
Nanomedicine in pancreatic cancer – A way forward?
|
Mayerle, Julia |
|
2016 |
16 |
3S |
p. S5-S6 2 p. |
artikel |
8 |
Novel roles for de-aminating enzymes in pancreatic cancer
|
Rhim, Andrew D. |
|
2016 |
16 |
3S |
p. S5- 1 p. |
artikel |
9 |
Pancreatic cancer research fund tissue bank
|
Ambily, Archana |
|
2016 |
16 |
3S |
p. S3- 1 p. |
artikel |
10 |
PET-CT in pancreatic cancer
|
Ghaneh, Paula |
|
2016 |
16 |
3S |
p. S2-S3 2 p. |
artikel |
11 |
PI3K/mTOR/MEK-targeted therapies in pancreatic and ovarian cancers
|
Burmi, Rajpal S. |
|
2016 |
16 |
3S |
p. S7- 1 p. |
artikel |
12 |
SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (± nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
|
Mukherjee, Somnath |
|
2016 |
16 |
3S |
p. S3-S4 2 p. |
artikel |
13 |
STAR_PAC: A Phase 1B study repurposing ATRA as stromal targeting agent along with gemcitabine and nab¬Paclitaxel for pancreatic cancer
|
Kocher, Hemant |
|
2016 |
16 |
3S |
p. S4-S5 2 p. |
artikel |
14 |
Targeting DNA damage response pathways to modulate pancreatic ductal adenocarcinoma sensitivity to DNA damaging agents
|
Maginn, Elaina N. |
|
2016 |
16 |
3S |
p. S8- 1 p. |
artikel |
15 |
Targeting pancreatic cancer stem cells
|
Heeschen, Christopher |
|
2016 |
16 |
3S |
p. S5- 1 p. |
artikel |
16 |
The integrin αvβ6 is a promising therapeutic target for treating PDAC
|
Marshall, John |
|
2016 |
16 |
3S |
p. S6- 1 p. |
artikel |
17 |
The role of EUS sampling in the management of all lesions affecting the pancreas
|
Hariharan, Deepak |
|
2016 |
16 |
3S |
p. S7-S8 2 p. |
artikel |
18 |
The role of image guided sampling in the management of solid, cystic and mixed lesions affecting the pancreas
|
Hariharan, Deepak |
|
2016 |
16 |
3S |
p. S7- 1 p. |
artikel |
19 |
Urine biomarkers in pancreatic cancer
|
Crnogorac-Jurcevic, Tatjana |
|
2016 |
16 |
3S |
p. S2- 1 p. |
artikel |
20 |
VOCAL: Virtual online consultations-advantages and limitations
|
Wherton, Joseph |
|
2016 |
16 |
3S |
p. S3- 1 p. |
artikel |